GlassScriptPhysician profile
David Edward Henry
NPI 1285861120
$15,445.23
in general payments reported to CMS, 2019-2025
18 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.42 · 2020: $305 · 2022: $12K · 2023: $727 · 2024: $2,005 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,313 · Food and Beverage: $541 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,313.42 |
| Food and Beverage | $541.13 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,717.09 | 2022-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $1,750.65 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medical Device Business Services, INC. | $305.00 | 2020 | |
| Davol INC. | $114.70 | 2025 | Phasix Mesh |
| Ethicon INC. | $100.00 | 2024 | |
| Lemaitre Vascular, INC. | $64.14 | 2023-2024 | Artegraft Vascular Graft, Anastoclip Gc 8cm (Medium) |
| Vertex Pharmaceuticals Incorporated | $59.16 | 2024-2025 | |
| Smith+Nephew, INC. | $55.38 | 2024-2025 | Renasys Go V2 Home |
| Phathom Pharmaceuticals, INC. | $52.17 | 2024 | Voquezna |
| Atricure, INC. | $48.95 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.28 | 2022-2024 | Gattex |
| Kci USA, INC. | $28.42 | 2019 | |
| Medtronic, INC. | $20.00 | 2022 | |
| Ethicon US, LLC | $17.79 | 2022 | |
| Bard Peripheral Vascular, INC. | $17.02 | 2025 | Glidepath |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $16.50 | 2025 | Mirotract |
| Acera Surgical, INC. | $16.19 | 2022 | |
| Csl Behring | $15.79 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.